Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatisis (NASH) are emerging as the most prevalent causes of liver disease in Western countries…
Publications / White Papers
Immunotherapy is an emerging class of cancer treatment, which stimulates the body’s immune system to fight cancer…
While using the body’s own immune system as a therapeutic approach to fight cancer is not a new concept in oncology, recent successes in clinical studies are making immunotherapy a reality…
As we know, more attention is being paid to blood pressure (BP) effects in new chemical entities under development for non-hypertension indications…
BioTelemetry Research performed a blinded reading to define the variability between inter-reader and intra-reader assessments…
Effect of Anagrelide on Cardiac Repolarization in Healthy Volunteers: A Randomized, Double-Blind, Placebo- and Positive-Controlled, Thorough QT Study
The assessment of drug-induced changes in the QT and QTc interval has become a necessary component of drug development…
Loxapine Delivered as a Thermally Generated Aerosol Does Not Prolong QTc in a Thorough QT/QTc Study in Healthy Subjects
Loxapine, which was introduced more than 35 years ago in the US, Canada, and Europe, has a well-established efficacy and safety profile in the treatment of schizophrenia…
Association of Segmental Wall Motion Abnormalities Occurring During Hemodialysis with Post-Dialysis Fatigue
Post-dialysis fatigue (PDF) is a common, debilitating symptom that remains poorly understood. Cardiac wall motion abnormalities (WMAs) may worsen during dialysis…
Many patients who have benefited from effective chemotherapy now face increased risks of morbidity and mortality from acute and delayed toxic effects of chemotherapeutic agents…
Correlating Biochemical, Histologic, and Magnetic Resonance Imaging Measures for Early Diagnosis of Osteoarthritis in the Pondnuki Model in Dogs
Although there are currently ways to assess articular cartilage degradation in osteoarthritis (OA) these measurements usually cannot be completed currently in a noninvasive, clinically relevant manner.
MR Diffusion Tensor Imaging (DTI) and Neuropsychological Testing for Neuronal Connectivity in Alzheimer’s Disease (AD) Patients
Alzheimer’s disease (AD), a neurodegenerative disorder associated with progressive functional decline, is initially diagnosed as a memory disorder accompanied by attentional and perceptual deficits.
join our Vice President of Musculoskeletal and Metabolic Imaging, Jonathan Riek, PhD, and AMRA’s Chief Scientific Officer & Co-Founder, Olof Dahlqvist Leinhard, PhD, as they present alternative, noninvasive imaging methods to determine body composition.
Key Takeaways from the New CSRC/FDA Meeting on Cardiac Safety and Cardiovascular Safety Issues in Oncology Drug Development Nov 1, 2017
Join Polina Voloshko, MD, Chief Medical Officer and Daniel Goodman, MD, Vice President and Medical Director, to learn about the updates from the new CSRC/FDA meeting on cardiac safety and cardiovascular safety issues in oncology drug development to optimize your clinical trial.
Optimize the Imaging in Clinical Trials by Aligning Operational Excellence and Scientific Expertise Sep 13, 2017
Join Ed Ashton, Ph.D., Vice President of Oncology Imaging and Danielle Lewis, M.S., PMP, Global Operations Account Manager, for an educational webinar discussing real-world scientific and operational examples of errors that can occur during your imaging clinical trial and how you can prevent them.
Join Richard Ehman, MD from the Mayo Clinic and BioTelemetry Research’s Jonathan Riek, PhD, VP, Musculoskeletal and Metabolic Imaging as they discuss non-invasive ways to assess NASH using imaging, including proton density fat fraction (PDFF), T1 relaxometry, magnetic resonance elastography (MRE), and the latest advances in MRE.
Join Svetlana Kolchinsky, MD, Director of Project Operations, as she discusses how to manage multi-protocol programs and build efficiencies while being a good partner. Key topics include next level planning for risk management and project/program oversight, successful project delivery and lessons learned.
In this free webinar, industry experts Edward Ashton, PhD and Polina Voloshko, MD will discuss the growing range of imaging modalities and analysis methods that are available for use in your clinical trials during oncology drug development.
BioTelemetry Research is proposing a service offering for evaluation of cardiac repolarization in early human trials, novel to the industry, called Dynamic Repolarization Analysis.
In this free webinar, industry experts Sandra Chica, MD and Polina Voloshko, MD aim to describe novel medical imaging approaches and methodologies to help sponsors maximize clinical trial efficiency along the development pathway.
Evaluation of Atrial Fibrillation and Other Arrhythmias within Clinical Trials and Clinical Practice4-28-15
In this free webinar learn how big data is transforming cardiac research. Presented by Polina Voloshko, MD, Chief Medical Officer, BioTelemetry Research, and Wayne M. Derkac, MD, Vice President of Medical Affairs, BioTelemetry.